Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by

Christos P Kyriakopoulos1,2, Konstantinos Sideris1, Iosif Taleb1,2

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine (C.P.K., K.S., I.T., E.M., R.H., E.T., E.D., K.S.S., T.L.J., J.C.F., J.S., T.C.H., S.G.D.), University of Utah Health and School of Medicine, Salt Lake City.

PubMed

Insights

Successful outcomes in acute decompensated heart failure-cardiogenic shock (ADHF-CS) are linked to specific clinical factors. Identifying these early can improve patient management and prognosis for this severe condition.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Heart Failure Research

Background:

  • Cardiogenic shock (CS) has diverse causes, with acute decompensated heart failure (ADHF)-CS being the most common.
  • Previous research primarily focused on acute myocardial infarction-CS, leaving ADHF-CS outcomes less understood.

Purpose of the Study:

  • To identify early clinical factors associated with successful outcomes in patients experiencing ADHF-CS.
  • To inform clinical management and guide future research for ADHF-CS.

Main Methods:

  • Evaluated 562 consecutive patients with ADHF-CS.
  • Defined primary endpoint as native heart survival (NHS) – survival to discharge without advanced heart failure therapies.
  • Analyzed associations between clinical data and NHS using logistic regression.

Main Results:

  • 63.5% of patients achieved NHS; 29.2% died; 7.3% received advanced therapies.
  • NHS patients had better hemodynamic profiles, lower vasoactive-inotropic scores, and fewer adverse events like cardiac arrest or acute kidney injury.
  • Key predictors of NHS included younger age, hypertension history, absence of cardiac arrest/AKI, lower pulmonary capillary wedge pressure, and higher tricuspid annular plane systolic excursion.

Conclusions:

  • Identified key clinical factors for improved management of ADHF-CS.
  • Highlighted the importance of right ventricular function, renal function, and mechanical circulatory support in ADHF-CS outcomes.
  • Further research into these factors is crucial for improving survival rates in ADHF-CS.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
762
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
131